The hypothesis: the overall survival of AML patients is influenced by AML type, age, genetic aberrancies, comorbidity and performance status of the patient as well as type of treatment.
ID
Bron
Aandoening
Goal: to determine overall survival of AML patients in the province of Friesland (NL) and to determine whether overall survival is dependent on the factors mentioned. Early death will also be determined.
Ondersteuning
Onderzoeksproduct en/of interventie
Uitkomstmaten
Primaire uitkomstmaten
none
Achtergrond van het onderzoek
Acute myeloid leukemia (AML) is a heterogeneous hematopoietic stem cell disease characterised by a proliferation of myeloblasts in the bone marrow. The incidence is 3 to 4 per 100.000. AML is a heterogeneous disease with may subtypes showing large differences in age, comorbidity, performance status and treatment of the patient.
Doel van het onderzoek
The hypothesis: the overall survival of AML patients is influenced by AML type, age, genetic aberrancies, comorbidity and performance status of the patient as well as type of treatment.
Onderzoeksopzet
31-12-2017
Onderzoeksproduct en/of interventie
none
Publiek
Wetenschappelijk
Belangrijkste voorwaarden om deel te mogen nemen (Inclusiecriteria)
retrospective observational population-based; all patients in Friesland
Belangrijkste redenen om niet deel te kunnen nemen (Exclusiecriteria)
retrospective observational population-based; all patients in Friesland
Opzet
Deelname
Opgevolgd door onderstaande (mogelijk meer actuele) registratie
Geen registraties gevonden.
Andere (mogelijk minder actuele) registraties in dit register
Geen registraties gevonden.
In overige registers
| Register | ID |
|---|---|
| NTR-new | NL5925 |
| NTR-old | NTR6105 |
| Ander register | VZ-NI-OTHER-Hemobase-007339 : RTPO980a |